An active group involved in important aspect of most disciplines within cardiology with all aspects of cardiovascular pharmacology, from basic pharmacology over clinical trials to clinical pharmacology.
A three day Annual Meeting to discuss clinical applicability and significance of new drugs and new data
Join the community and access your benefits.
Access the Official Journal of the Working Group.
To understand the methodological issues of design and how to conduct and interpret clinical trials.
Taking advantages of educational resources to improve and develop your knowledge.
Access a selection of valuable scientific articles and position papers.
New group dedicated to young professionals under 40 with a special interest in cardiovascular pharmacotherapy and clinical trials.
The ESC Working Group on Cardiovascular Pharmacotherapy is proud to be delivering an engaging and interactive 2 day course to improve the professional knowledge and skills required to plan and deliver successful cardiovascular pharmacotherapy clinical trials.
The European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy is proud to be delivering an engaging and interactive 2 day course to improve the professional knowledge and skills required to plan and deliver successful cardiovascular pharmacotherapy clinical trials.
The Frontiers in CardioVascular Biology meetings are increasingly considered as one of the most relevant exchange platforms for basic and translational cardiovascular biology.
EuroCVP 2018 will provide up to date discussions regarding the clinical applicability and significance of new drugs and data. The congress will feature high quality plenary and keynote lectures, focused debates in topical areas of therapy and a large number of free communications which will be presented in e-poster and guided poster sessions.
Every year the Working Group on Cardiovascular Pharmacotherapy organises EuroCVP Meeting to gather pharmacologists, pharmacists, research nurses and personnel, as well as general cardiologists with an interest in cardiovascular pharmacotherapy, pharmacology and heart failure.
All cardiologists are concerned by pharmacology and drugs therapy, thus, they should all participate and contribute to EuroCVP.
During the meeting, focus is made on key treatment breakthroughs, clinical applicability and significance of new drugs and new data. Since 2015, a Clinical Trials Workshop is held in conjunction to the main conference to give a focused view of the clinical trial arena, including trial methodology, trial challenges, trial interpretation and analysis, regulatory issues and good clinical practice.
European Society of Cardiology
European Heart HouseLes Templiers2035 Route des CollesCS 80179 Biot
06903Sophia Antipolis, France
Our mission: To reduce the burden of cardiovascular disease
© 2017 European Society of Cardiology. All rights reserved